NeuBase Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBSE and other ETFs, options, and stocks.About NBSE
NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines.
CEOTodd P. Branning
CEOTodd P. Branning
Employees37
Employees37
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2009
Founded2009
Employees37
Employees37
NBSE Key Statistics
Market cap1.66M
Market cap1.66M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume60.61K
Average volume60.61K
High today$0.45
High today$0.45
Low today$0.412
Low today$0.412
Open price$0.422
Open price$0.422
Volume72.17K
Volume72.17K
52 Week high$4.80
52 Week high$4.80
52 Week low$0.39
52 Week low$0.39